Population Pharmacokinetic Analysis of Dutogliptin, a Selective Dipeptidyl Peptidase-4 Inhibitor Publication Population Pharmacokinetic Analysis of Dutogliptin, a Selective Dipeptidyl Peptidase-4 Inhibitor Dutogliptin is a selective dipeptidyl peptidase-4 inhibitor shown to be efficacious and safe in patients…webdev2014 年 7 月 14 日
A Re-evaluation and Validation of Ontogeny Functions for CYPs 1A2 and 3A4 Based on In Vivo Data Publication A Re-evaluation and Validation of Ontogeny Functions for CYPs 1A2 and 3A4 Based on In Vivo Data Current cytochrome P450 (CYP) 1A2 and 3A4 ontogeny profiles, which are derived mainly from in…webdev2014 年 7 月 1 日
Conversion from Twice- to Once-daily Tacrolimus in Pediatric Kidney Recipients: A Pharmacokinetic and Bioequivalence Study Publication Conversion from Twice- to Once-daily Tacrolimus in Pediatric Kidney Recipients: A Pharmacokinetic and Bioequivalence Study The objectives of this study were to investigate pharmacokinetic and pharmacogenetic parameters during the conversion…webdev2014 年 6 月 1 日
Population Pharmacokinetics and Bayesian Estimation of Tacrolimus Exposure in Pediatric Liver Transplant Recipients Publication Population Pharmacokinetics and Bayesian Estimation of Tacrolimus Exposure in Pediatric Liver Transplant Recipients Objectives of this study were to develop a population pharmacokinetic (PopPK) model for tacrolimus in…webdev2014 年 6 月 1 日
The Posology of Oseltamivir in Infants with Influenza Infection Using a Population Pharmacokinetic Approach Publication The Posology of Oseltamivir in Infants with Influenza Infection Using a Population Pharmacokinetic Approach webdev2014 年 5 月 27 日
Model-based Meta-analysis for Quantifying Paclitaxel Dose Response in Cancer Patients Publication Model-based Meta-analysis for Quantifying Paclitaxel Dose Response in Cancer Patients Model-based meta-analysis of dose response is a sophisticated method to guide dose and regimen selection.…webdev2014 年 5 月 21 日
Changes in Individual Drug-independent System Parameters during Virtual Pediatric Pharmacokinetic Trials: Introducing Time-varying Physiology into a Pediatric PBPK Model Publication Changes in Individual Drug-independent System Parameters during Virtual Pediatric Pharmacokinetic Trials: Introducing Time-varying Physiology into a Pediatric PBPK Model Although both POPPK and physiologically based pharmacokinetic (PBPK) models can account for age and other covariates within…webdev2014 年 5 月 1 日
Evaluation of Tumor Size Response Metrics to Predict Survival in Oncology Clinical Trials Publication Evaluation of Tumor Size Response Metrics to Predict Survival in Oncology Clinical Trials Model-based drug development in oncology is still lagging despite a good momentum in the clinical…webdev2014 年 4 月 1 日
Exploratory Modeling and Simulation to Support Development of Motesanib in Asian Patients with Non-small Cell Lung Cancer Based on MONET1 Study Results Publication Exploratory Modeling and Simulation to Support Development of Motesanib in Asian Patients with Non-small Cell Lung Cancer Based on MONET1 Study Results The motesanib phase III MONET1 study failed to show improvement in overall survival (OS) in…webdev2014 年 4 月 1 日
Population Pharmacokinetics of Azithromycin in Whole Blood, Peripheral Blood Mononuclear Cells, and Polymorphonuclear Cells in Healthy Adults Publication Population Pharmacokinetics of Azithromycin in Whole Blood, Peripheral Blood Mononuclear Cells, and Polymorphonuclear Cells in Healthy Adults Azithromycin's extensive distribution to proinflammatory cells, including peripheral blood mononuclear cells (PBMCs) and polymorphonuclear cells…webdev2014 年 3 月 5 日